Literature DB >> 23348723

Prediction of mutant mRNA splice isoforms by information theory-based exon definition.

Eliseos J Mucaki1, Ben C Shirley, Peter K Rogan.   

Abstract

Mutations that affect mRNA splicing often produce multiple mRNA isoforms, resulting in complex molecular phenotypes. Definition of an exon and its inclusion in mature mRNA relies on joint recognition of both acceptor and donor splice sites. This study predicts cryptic and exon-skipping isoforms in mRNA produced by splicing mutations from the combined information contents (R(i), which measures binding-site strength, in bits) and distribution of the splice sites defining these exons. The total information content of an exon (R(i),total) is the sum of the R(i) values of its acceptor and donor splice sites, adjusted for the self-information of the distance separating these sites, that is, the gap surprisal. Differences between total information contents of an exon (ΔR(i,total)) are predictive of the relative abundance of these exons in distinct processed mRNAs. Constraints on splice site and exon selection are used to eliminate nonconforming and poorly expressed isoforms. Molecular phenotypes are computed by the Automated Splice Site and Exon Definition Analysis (http://splice.uwo.ca) server. Predictions of splicing mutations were highly concordant (85.2%; n = 61) with published expression data. In silico exon definition analysis will contribute to streamlining assessment of abnormal and normal splice isoforms resulting from mutations.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23348723     DOI: 10.1002/humu.22277

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  18 in total

1.  Experimental assessment of splicing variants using expression minigenes and comparison with in silico predictions.

Authors:  Neeraj Sharma; Patrick R Sosnay; Anabela S Ramalho; Christopher Douville; Arianna Franca; Laura B Gottschalk; Jeenah Park; Melissa Lee; Briana Vecchio-Pagan; Karen S Raraigh; Margarida D Amaral; Rachel Karchin; Garry R Cutting
Journal:  Hum Mutat       Date:  2014-09-10       Impact factor: 4.878

2.  Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.

Authors:  Xiaohong R Yang; Beena C R Devi; Hyuna Sung; Jennifer Guida; Eliseos J Mucaki; Yanzi Xiao; Ana Best; Lisa Garland; Yi Xie; Nan Hu; Maria Rodriguez-Herrera; Chaoyu Wang; Kristine Jones; Wen Luo; Belynda Hicks; Tieng Swee Tang; Karobi Moitra; Peter K Rogan; Michael Dean
Journal:  Breast Cancer Res Treat       Date:  2017-06-29       Impact factor: 4.872

3.  A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.

Authors:  Sumeet A Khetarpal; Xuemei Zeng; John S Millar; Cecilia Vitali; Amritha Varshini Hanasoge Somasundara; Paolo Zanoni; James A Landro; Nicole Barucci; William J Zavadoski; Zhiyuan Sun; Hans de Haard; Ildikó V Toth; Gina M Peloso; Pradeep Natarajan; Marina Cuchel; Sissel Lund-Katz; Michael C Phillips; Alan R Tall; Sekar Kathiresan; Paul DaSilva-Jardine; Nathan A Yates; Daniel J Rader
Journal:  Nat Med       Date:  2017-08-21       Impact factor: 53.440

4.  Expanding the mutational spectrum of LZTR1 in schwannomatosis.

Authors:  Irene Paganini; Vivian Y Chang; Gabriele L Capone; Jeremie Vitte; Matteo Benelli; Lorenzo Barbetti; Roberta Sestini; Eva Trevisson; Theo Jm Hulsebos; Marco Giovannini; Stanley F Nelson; Laura Papi
Journal:  Eur J Hum Genet       Date:  2014-10-22       Impact factor: 4.246

5.  FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.

Authors:  Paolo Peterlongo; Irene Catucci; Mara Colombo; Laura Caleca; Eliseos Mucaki; Massimo Bogliolo; Maria Marin; Francesca Damiola; Loris Bernard; Valeria Pensotti; Sara Volorio; Valentina Dall'Olio; Alfons Meindl; Claus Bartram; Christian Sutter; Harald Surowy; Valérie Sornin; Marie-Gabrielle Dondon; Séverine Eon-Marchais; Dominique Stoppa-Lyonnet; Nadine Andrieu; Olga M Sinilnikova; Gillian Mitchell; Paul A James; Ella Thompson; Marina Marchetti; Cristina Verzeroli; Carmen Tartari; Gabriele Lorenzo Capone; Anna Laura Putignano; Maurizio Genuardi; Veronica Medici; Isabella Marchi; Massimo Federico; Silvia Tognazzo; Laura Matricardi; Simona Agata; Riccardo Dolcetti; Lara Della Puppa; Giulia Cini; Viviana Gismondi; Valeria Viassolo; Chiara Perfumo; Maria Antonietta Mencarelli; Margherita Baldassarri; Bernard Peissel; Gaia Roversi; Valentina Silvestri; Piera Rizzolo; Francesca Spina; Caterina Vivanet; Maria Grazia Tibiletti; Maria Adelaide Caligo; Gaetana Gambino; Stefania Tommasi; Brunella Pilato; Carlo Tondini; Chiara Corna; Bernardo Bonanni; Monica Barile; Ana Osorio; Javier Benitez; Luisa Balestrino; Laura Ottini; Siranoush Manoukian; Marco A Pierotti; Alessandra Renieri; Liliana Varesco; Fergus J Couch; Xianshu Wang; Peter Devilee; Florentine S Hilbers; Christi J van Asperen; Alessandra Viel; Marco Montagna; Laura Cortesi; Orland Diez; Judith Balmaña; Jan Hauke; Rita K Schmutzler; Laura Papi; Miguel Angel Pujana; Conxi Lázaro; Anna Falanga; Kenneth Offit; Joseph Vijai; Ian Campbell; Barbara Burwinkel; Anders Kvist; Hans Ehrencrona; Sylvie Mazoyer; Sara Pizzamiglio; Paolo Verderio; Jordi Surralles; Peter K Rogan; Paolo Radice
Journal:  Hum Mol Genet       Date:  2015-06-30       Impact factor: 6.150

6.  Small-scale high-throughput sequencing-based identification of new therapeutic tools in cystic fibrosis.

Authors:  Jennifer Bonini; Jessica Varilh; Caroline Raynal; Corinne Thèze; Emmanuelle Beyne; Marie-Pierre Audrezet; Claude Ferec; Thierry Bienvenu; Emmanuelle Girodon; Sylvie Tuffery-Giraud; Marie Des Georges; Mireille Claustres; Magali Taulan-Cadars
Journal:  Genet Med       Date:  2015-01-08       Impact factor: 8.822

7.  Validation of predicted mRNA splicing mutations using high-throughput transcriptome data.

Authors:  Coby Viner; Stephanie N Dorman; Ben C Shirley; Peter K Rogan
Journal:  F1000Res       Date:  2014-01-13

Review 8.  Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.

Authors:  Natasha Caminsky; Eliseos J Mucaki; Peter K Rogan
Journal:  F1000Res       Date:  2014-11-18

9.  Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer.

Authors:  Stephanie N Dorman; Coby Viner; Peter K Rogan
Journal:  Sci Rep       Date:  2014-11-14       Impact factor: 4.379

10.  A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.

Authors:  Eliseos J Mucaki; Natasha G Caminsky; Ami M Perri; Ruipeng Lu; Alain Laederach; Matthew Halvorsen; Joan H M Knoll; Peter K Rogan
Journal:  BMC Med Genomics       Date:  2016-04-11       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.